Form 4 for CRVS Corvus Pharmaceuticals, Inc.
Accepted 2022-12-20 00:00:00 ET · period of report 2022-12-20 · accession 0001567619-22-021876 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-20 | 2022-12-20 | CRVS | Jones William Benton | See Remarks | P - Purchase | $0.79 | +20.0K | 133.8K | +18% | +$15.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-20 | P | A | 20,000 | $0.79 | 133,773 | D | — | — |